I was holding CYDY from .30 and sold in the last run up just before the Citreon hit job. I've been plotting a reentry however, I really wanted Cytodyn's rebuttal to Adam F. at STAT to be more data driven. Everyone into trading knows that Adam F is a dirt bag and has a horrible track record. Sadly, there are retail investors who have no idea who he is and sell because he can reach shareholders through STAT. Since CYDY is OTC, retail makes up a large portion of the shareholders.
I am absolutely certain CYDY is going to explode on news of uplisting to Nasdaq. That goes without question. The question on my mind is: how long will it bleed before that news breaks? It's possible that the uplisting news drops before efficacy data and the FOMO is building....